Hepatitis C Virus Clearance in Older Adults
ConclusionIn a real‐world setting, DAAs are safe and effective in older adults with HCV‐related advanced fibrosis or cirrhosis. Individuals with preserved albumin synthesis and fewer than 3 comorbidities at baseline have the most to gain from long‐term DAA therapy.
Source: Journal of the American Geriatrics Society - Category: Geriatrics Authors: Antonio Massimo Ippolito, Angelo Iacobellis, Michele Milella, Fabio Conti, Vincenzo Messina, Maria Rosa Valvano, Grazia Anna Niro, Filomena Morisco, Michele Barone, Antonio Patrizio Termite, Giuseppina Brancaccio, Angelo Andriulli Tags: Clinical Investigation Source Type: research
More News: Antiviral Therapy | Cancer & Oncology | Carcinoma | Cirrhosis | Geriatrics | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Urology & Nephrology